The Bank Of New York Mellon Corporation rose 1.18% in intraday trading. The company's stock price increase may be attributed to the recent news events, including Truist adjusting its price target on the Bank of New York Mellon, and Chemomab Therapeutics Ltd. announcing financial results and plans to implement an ADS ratio change adjustment.
Comments
No comments yet